Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3 World

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

: NCT04401202 Eligibility Criteria

Page standards status: Informative

Raw ttl | Download


@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

<http://hl7.org/fhir/Group/189713> a fhir:Group ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "189713"] ; # 
  fhir:meta [
     fhir:versionId [ fhir:v "3" ] ;
     fhir:lastUpdated [ fhir:v "2026-08-05T07:33:36.353Z"^^xsd:dateTime ]
  ] ; # 
  fhir:language [ fhir:v "en"] ; # 
  fhir:text [
     fhir:status [ fhir:v "extensions" ] ;
     fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n  <table class=\"narrative-table\">\n    <tbody>\n<tr>\n\n\n<th colspan=\"2\" scope=\"row\" class=\"row-header\"><a name=\"metadata\"> </a>Metadata</th>\n\n\n</tr>\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Title</th>\n\n\n\n<td class=\"content-container\">NCT04401202 Eligibility Criteria</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n  \n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Identifier</th>\n\n\n\n<td class=\"content-container\">189713</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Steward (Publisher)</th>\n\n\n\n<td class=\"content-container\">Computable Publishing LLC</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Description</th>\n\n\n\n<td class=\"content-container\"><div><p>Inclusion Criteria:</p>\n<ul>\n<li>Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia</li>\n<li>Adult (18 Years and above)</li>\n<li>Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative).</li>\n<li>Understands and agrees to comply with planned study procedures.</li>\n<li>Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH.\nExclusion Criteria:</li>\n<li>Patients with pneumonia or severe illness requiring admission to ICU.</li>\n<li>Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) &lt; 30) or end stage renal disease requiring dialysis</li>\n<li>Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) &gt; 5 times the upper limit of normal).</li>\n<li>Pregnancy or breast feeding.</li>\n<li>Anticipated transfer to another hospital which is not a study site within 72 hours.</li>\n<li>Allergy to any study medication.</li>\n</ul>\n</div></td>\n\n\n</tr>\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Copyright</th>\n\n\n\n<td class=\"content-container\"><div><p>Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).</p>\n</div></td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n  <th colspan=\"2\" scope=\"row\" class=\"row-header\">Generated using version 0.5.6 of the sample-content-ig Liquid templates</th>\n</tr>\n\n    </tbody>\n  </table>\n</div>"^^rdf:XMLLiteral ]
  ] ; # 
  fhir:extension ( [
     fhir:url [
       fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status"^^xsd:anyURI ;
       fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status>
     ] ;
     fhir:value [
       a fhir:CodeableConcept ;
       fhir:coding ( [
         fhir:system [
           fhir:v "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type"^^xsd:anyURI ;
           fhir:l <http://terminology.hl7.org/CodeSystem/cited-artifact-status-type>
         ] ;
         fhir:code [ fhir:v "active" ] ;
         fhir:display [ fhir:v "Active" ]
       ] )
     ]
  ] [
     fhir:url [
       fhir:v "http://hl7.org/fhir/StructureDefinition/artifact-author"^^xsd:anyURI ;
       fhir:l <http://hl7.org/fhir/StructureDefinition/artifact-author>
     ] ;
     fhir:value [
       a fhir:ContactDetail ;
       fhir:name [ fhir:v "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter" ]
     ]
  ] [
     fhir:url [
       fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as"^^xsd:anyURI ;
       fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as>
     ] ;
     fhir:value [
       a fhir:Markdown ;
       fhir:v "NCT04401202 Eligibility Criteria [Database Entry: FHIR Group Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 189713. Revised 2026-08-05. Available at: https://fevir.net/resources/Group/189713. Computable resource at: https://fevir.net/resources/Group/189713#json."
     ]
  ] ) ; # 
  fhir:url [
     fhir:v "https://fevir.net/resources/Group/189713"^^xsd:anyURI ;
     fhir:l <https://fevir.net/resources/Group/189713>
  ] ; # 
  fhir:identifier ( [
     fhir:type [
       fhir:coding ( [
         fhir:system [
           fhir:v "http://terminology.hl7.org/CodeSystem/v2-0203"^^xsd:anyURI ;
           fhir:l <http://terminology.hl7.org/CodeSystem/v2-0203>
         ] ;
         fhir:code [ fhir:v "ACSN" ] ;
         fhir:display [ fhir:v "Accession ID" ]
       ] ) ;
       fhir:text [ fhir:v "FEvIR Object Identifier" ]
     ] ;
     fhir:system [
       fhir:v "https://fevir.net/FOI"^^xsd:anyURI ;
       fhir:l <https://fevir.net/FOI>
     ] ;
     fhir:value [ fhir:v "189713" ] ;
     fhir:assigner [
       fhir:display [ fhir:v "Computable Publishing LLC" ]
     ]
  ] [
     fhir:type [
       fhir:text [ fhir:v "FEvIR Linking Identifier" ]
     ] ;
     fhir:system [
       fhir:v "https://fevir.net/FLI"^^xsd:anyURI ;
       fhir:l <https://fevir.net/FLI>
     ] ;
     fhir:value [ fhir:v "NCT04401202 Eligibility Criteria" ] ;
     fhir:assigner [
       fhir:display [ fhir:v "Computable Publishing LLC" ]
     ]
  ] ) ; # 
  fhir:name [ fhir:v "NCT04401202_Eligibility_Criteria"] ; # 
  fhir:title [ fhir:v "NCT04401202 Eligibility Criteria"] ; # 
  fhir:status [ fhir:v "active"] ; # 
  fhir:publisher [ fhir:v "Computable Publishing LLC"] ; # 
  fhir:contact ( [
     fhir:telecom ( [
       fhir:system [ fhir:v "email" ] ;
       fhir:value [ fhir:v "support@computablepublishing.com" ]
     ] )
  ] ) ; # 
  fhir:description [ fhir:v "Inclusion Criteria:\n* Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia\n* Adult (18 Years and above)\n* Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative).\n* Understands and agrees to comply with planned study procedures.\n* Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH.\nExclusion Criteria:\n* Patients with pneumonia or severe illness requiring admission to ICU.\n* Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) \\< 30) or end stage renal disease requiring dialysis\n* Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) \\> 5 times the upper limit of normal).\n* Pregnancy or breast feeding.\n* Anticipated transfer to another hospital which is not a study site within 72 hours.\n* Allergy to any study medication."] ; # 
  fhir:copyright [ fhir:v "Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse)."] ; # 
  fhir:membership [ fhir:v "conceptual"] ; # 
  fhir:combinationMethod [ fhir:v "all-of"] ; # 
  fhir:characteristic ( [
     fhir:code [
       fhir:text [ fhir:v "Defined by CodeableConcept" ]
     ] ;
     fhir:value [
       a fhir:CodeableConcept ;
       fhir:text [ fhir:v "Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia" ]
     ] ;
     fhir:exclude [ fhir:v false ] ;
     fhir:description [ fhir:v "Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia" ]
  ] [
     fhir:code [
       fhir:text [ fhir:v "Defined by CodeableConcept" ]
     ] ;
     fhir:value [
       a fhir:CodeableConcept ;
       fhir:text [ fhir:v "Adult (18 Years and above)" ]
     ] ;
     fhir:exclude [ fhir:v false ] ;
     fhir:description [ fhir:v "Adult (18 Years and above)" ]
  ] [
     fhir:code [
       fhir:text [ fhir:v "Defined by CodeableConcept" ]
     ] ;
     fhir:value [
       a fhir:CodeableConcept ;
       fhir:text [ fhir:v "Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative)." ]
     ] ;
     fhir:exclude [ fhir:v false ] ;
     fhir:description [ fhir:v "Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative)." ]
  ] [
     fhir:code [
       fhir:text [ fhir:v "Defined by CodeableConcept" ]
     ] ;
     fhir:value [
       a fhir:CodeableConcept ;
       fhir:text [ fhir:v "Understands and agrees to comply with planned study procedures." ]
     ] ;
     fhir:exclude [ fhir:v false ] ;
     fhir:description [ fhir:v "Understands and agrees to comply with planned study procedures." ]
  ] [
     fhir:code [
       fhir:text [ fhir:v "Defined by CodeableConcept" ]
     ] ;
     fhir:value [
       a fhir:CodeableConcept ;
       fhir:text [ fhir:v "Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH." ]
     ] ;
     fhir:exclude [ fhir:v false ] ;
     fhir:description [ fhir:v "Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH." ]
  ] [
     fhir:code [
       fhir:text [ fhir:v "Defined by CodeableConcept" ]
     ] ;
     fhir:value [
       a fhir:CodeableConcept ;
       fhir:text [ fhir:v "Patients with pneumonia or severe illness requiring admission to ICU." ]
     ] ;
     fhir:exclude [ fhir:v true ] ;
     fhir:description [ fhir:v "Patients with pneumonia or severe illness requiring admission to ICU." ]
  ] [
     fhir:code [
       fhir:text [ fhir:v "Defined by CodeableConcept" ]
     ] ;
     fhir:value [
       a fhir:CodeableConcept ;
       fhir:text [ fhir:v "Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) \\< 30) or end stage renal disease requiring dialysis" ]
     ] ;
     fhir:exclude [ fhir:v true ] ;
     fhir:description [ fhir:v "Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) \\< 30) or end stage renal disease requiring dialysis" ]
  ] [
     fhir:code [
       fhir:text [ fhir:v "Defined by CodeableConcept" ]
     ] ;
     fhir:value [
       a fhir:CodeableConcept ;
       fhir:text [ fhir:v "Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) \\> 5 times the upper limit of normal)." ]
     ] ;
     fhir:exclude [ fhir:v true ] ;
     fhir:description [ fhir:v "Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) \\> 5 times the upper limit of normal)." ]
  ] [
     fhir:code [
       fhir:text [ fhir:v "Defined by CodeableConcept" ]
     ] ;
     fhir:value [
       a fhir:CodeableConcept ;
       fhir:text [ fhir:v "Pregnancy or breast feeding." ]
     ] ;
     fhir:exclude [ fhir:v true ] ;
     fhir:description [ fhir:v "Pregnancy or breast feeding." ]
  ] [
     fhir:code [
       fhir:text [ fhir:v "Defined by CodeableConcept" ]
     ] ;
     fhir:value [
       a fhir:CodeableConcept ;
       fhir:text [ fhir:v "Anticipated transfer to another hospital which is not a study site within 72 hours." ]
     ] ;
     fhir:exclude [ fhir:v true ] ;
     fhir:description [ fhir:v "Anticipated transfer to another hospital which is not a study site within 72 hours." ]
  ] [
     fhir:code [
       fhir:text [ fhir:v "Defined by CodeableConcept" ]
     ] ;
     fhir:value [
       a fhir:CodeableConcept ;
       fhir:text [ fhir:v "Allergy to any study medication." ]
     ] ;
     fhir:exclude [ fhir:v true ] ;
     fhir:description [ fhir:v "Allergy to any study medication." ]
  ] ) . #